Similar articles for PMID: 28005970

Year	Number of Results
2009	9
2010	7
2011	7
2012	14
2013	20
2014	29
2015	36
2016	46
2017	45
2018	31
2019	42
2020	37
2021	27
2022	12
2023	6
2024	0

1

Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer.

Cao GD, Xu XY, Zhang JW, Chen B, Xiong MM. Cao GD, et al. PLoS One. 2016 Dec 22;11(12):e0168085. doi: 10.1371/journal.pone.0168085. eCollection 2016. PLoS One. 2016. PMID: 28005970 Free PMC article.

2

Positive prognostic value of HER2-HER3 co-expression and p-mTOR in gastric cancer patients.

Cao GD, Chen K, Chen B, Xiong MM. Cao GD, et al. BMC Cancer. 2017 Dec 12;17(1):841. doi: 10.1186/s12885-017-3851-y. BMC Cancer. 2017. PMID: 29233126 Free PMC article.

3

Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.

Li S, Wang Z, Huang J, Cheng S, Du H, Che G, Peng Y. Li S, et al. BMC Cancer. 2016 Nov 11;16(1):877. doi: 10.1186/s12885-016-2940-7. BMC Cancer. 2016. PMID: 27835987 Free PMC article. Review.

4

Prognostic role of p-mTOR expression in cancer tissues and metastatic lymph nodes in pT2b gastric cancer.

An JY, Kim KM, Choi MG, Noh JH, Sohn TS, Bae JM, Kim S. An JY, et al. Int J Cancer. 2010 Jun 15;126(12):2904-13. doi: 10.1002/ijc.24872. Int J Cancer. 2010. PMID: 19739122 Free article.

5

A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.

Korkolopoulou P, Levidou G, Trigka EA, Prekete N, Karlou M, Thymara I, Sakellariou S, Fragkou P, Isaiadis D, Pavlopoulos P, Patsouris E, Saetta AA. Korkolopoulou P, et al. BJU Int. 2012 Dec;110(11 Pt C):E1237-48. doi: 10.1111/j.1464-410X.2012.11569.x. Epub 2012 Oct 29. BJU Int. 2012. PMID: 23107319

6

The role of mTOR and phospho-p70S6K in pathogenesis and progression of gastric carcinomas: an immunohistochemical study on tissue microarray.

Xiao L, Wang YC, Li WS, Du Y. Xiao L, et al. J Exp Clin Cancer Res. 2009 Dec 13;28(1):152. doi: 10.1186/1756-9966-28-152. J Exp Clin Cancer Res. 2009. PMID: 20003385 Free PMC article.

7

Activation of mammalian target of rapamycin pathway confers adverse outcome in nonsmall cell lung carcinoma.

Liu D, Huang Y, Chen B, Zeng J, Guo N, Zhang S, Liu L, Xu H, Mo X, Li W. Liu D, et al. Cancer. 2011 Aug 15;117(16):3763-73. doi: 10.1002/cncr.25959. Epub 2011 Mar 8. Cancer. 2011. PMID: 21387259 Free article.

8

E2F2 inhibition induces autophagy via the PI3K/Akt/mTOR pathway in gastric cancer.

Li H, Zhao S, Shen L, Wang P, Liu S, Ma Y, Liang Z, Wang G, Lv J, Qiu W. Li H, et al. Aging (Albany NY). 2021 Apr 21;13(10):13626-13643. doi: 10.18632/aging.202891. Epub 2021 Apr 21. Aging (Albany NY). 2021. PMID: 34091441 Free PMC article.

9

Immunohistochemical analysis of the mTOR pathway in intrahepatic cholangiocarcinoma.

Wang Z, Zheng T, Wu Q, Wang J, Wu C, Wang J. Wang Z, et al. Neoplasma. 2012;59(2):137-41. doi: 10.4149/neo_2012_018. Neoplasma. 2012. PMID: 22248270

10

LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients.

Cheng X, Zheng Z, Bu Z, Wu X, Zhang L, Xing X, Wang X, Hu Y, Du H, Li L, Li S, Zhou R, Wen XZ, Ji JF. Cheng X, et al. PLoS One. 2015 Apr 7;10(4):e0121559. doi: 10.1371/journal.pone.0121559. eCollection 2015. PLoS One. 2015. PMID: 25849595 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

325 results

Results by year